BBC icon

Virtus LifeSci Biotech Clinical Trials ETF
BBC

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $8.57M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.57M
2
+$624K
3
+$469K
4
BAAM
Baker Avenue Asset Management
California
+$267K
5
Jane Street
Jane Street
New York
+$146K

Top Sellers

1
-$6.23M
2
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.57M
2
$624K
3
$565K
4
$469K
5
$267K
6
$52K
7
$8.14K
8
$8K
9
$7K
10
$5K
11
–
12
–